AVTR | AvantorNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$15.59
-$0.02 (-0.13%)

Avantor (AVTR) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.

The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $15.59 vs 50 $15.54 / 200 $11.23
Projection
No cross projected
Test
No active test
Last cross
Golden cross 3 Aug 2026 ยท projected 22 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $16.05 vs 50 $11.25 / 200 $17.90
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
between the two $15.59 vs 50 $16.07 / 200 $13.61
Projection
No cross projected
Test
No active test
Last cross
Golden cross 16 Jun 2026 ยท projected 29 bars out

Cross history

20
crosses on record since 2020
10 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
3 Aug 2026Golden steepdaily22 bars outNot tested
16 Jun 2026Golden4-hour29 bars outNot tested
17 Nov 2025Death4-hour28 bars outNot tested
17 Oct 2025Golden4-hour29 bars outNot tested
20 Nov 2024Deathdaily21 bars outNot tested

About AVTR

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$116M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.